跳至主要内容
临床试验/JPRN-UMIN000011717
JPRN-UMIN000011717已完成未知

Determination of effective remodeling duration after thoracic endovascular repair for type B aortic dissection - Determination of effective remodeling duration after thoracic endovascular repair for type B aortic dissection

Osaka University Graduate school of medicine0 个研究点目标入组 100 人开始时间: 2013年9月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Less than 20 years of age 2.Patients with unknown date of onset of dissection 3.Absence of false lumen 5mm or greater in the descending aorta(distal to potential implantation site) 4.A lesion of the basilar aorta, ascending aorta, aortic arch, or abdominal aorta, which requires treatment 5.Treatment history of aneurysms of the aortic arch, descending aorta, or abdominal aorta 6.Patients with infective aortitis or systemic infection for whom endoprosthesis infection is suspected. 7.Continuously in shock state 8.Complication of severe organ disorder a.Low cardiac function b.Advanced Mitral/Aortic regurgitation c.Low respiratory function d.Hepatic cirrhosis e.Irreversible renal failure 9.Patients who have undergone coronary angioplasty within 2 weeks of the procedure 10.Patients with untreated and clinically significant coronary artery disease which requires revascularization 11.Patients with active peptic ulcer 12.Patients who have had cerebral infarction within 4 weeks after the procedure 13.Patients with a life expectancy of less than 12 months due to a non-aortic-related pre-operative complication 14.Pregnant women 15.Major surgery within 30 days of the procedure 16Connective tissue disorder 17.Participation in another clinical study in the past year 18.History of drug abuse, such as narcotics 19.Tortuous aorta or iliac artery for which the endoprosthesis access is considered impossible 20.A case that requires celiac artery closure as a part of treatment 21.Patients to be treated with devices other than CTAG 22.With history of allergy to endoprosthesis materials or contrast agent 23.Other patients for which treatment with endoprosthesis intervention under general anesthesia is considered inappropriate

研究者

相似试验